Nirmatrelvir/ritonavir use in patients with COVID-19 on hemodialysis: a case series
Description
Patients undergoing hemodialysis (HD) are particularly vulnerable to coronavirus disease 2019 (COVID-19) and are at increased risk of developing severe infection. However, given the exclusion of such patients from clinical trials, there are limited
